Lilly reports Phase 3 data showing retatrutide delivered substantial weight loss, reduced knee pain, and improved ...

Bengaluru: Are rushed mornings silently sabotaging your child's health? If your household operates on a \"wake up, get ready, ...

A novel triple receptor agonist conferred weight loss of up to 28.7% at 68 weeks and reductions in pain for adults with ...

Health officials say an infant botulism outbreak tied to ByHeart baby formula has been expanded to include all illnesses ...

Topline phase 3 results show retatrutide led to meaningful weight reduction and pain relief in adults with overweight or ...

Lilly’s first Phase III results for retatrutide show unprecedented weight loss and marked reductions in osteoarthritis pain, ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much ...

Some patients dropped out of the trial early because they had lost so much weight.

Discover why Eli Lilly and Company's retatrutide weight loss breakthrough positions LLY as a leader in obesity therapeutics.